Skip to main content

Table 1 Patient histopathologic and surgery details

From: Impact of surgical resection extension on outcome for primary well-differentiated thyroid cancer—a retrospective analysis

Parameter

Total

One-stage surgery

Two-stage surgery

n (%)

n = 87

n = 56 (64%)

n = 31 (36%)

Female gender

53 (61%)

34 (61%)

19 (61%)

Age (years) [median (range)]

49 (16–84)

49.5 (20–84)

48 (16–81)

Tumor histopathology

 Papillary thyroid cancer

73 (84%)

48 (86%)

25 (81%)

  Papillary microcarcinoma

27

23

4

 Follicular thyroid cancer

14 (16%)

8 (14%)

6 (19%)

  Minimally invasive follicular thyroid cancer

3

3

0

T stage

 pT1

49 (56%)

36 (64%)

13 (42%)

 pT2

16 (18%)

7 (12%)

9 (29%)

 pT3

17 (20%)

11 (20%)

6 (19%)

 pT4

5 (6%)

2 (4%)

3 (10%)

Lymph node metastasis (pNpos)a

21/55 (38%)

12/26 (46%)

9/29 (31%)

 Papillary thyroid cancer

20

12

8

 Follicular thyroid cancer

1

0

1

Synchronous distant metastasis

12 (14%)

11 (20%)

1 (3%)

 Lung

8

8

0

 Bone

6

6

0

 Liver

1

1

0

 Soft tissue

3

2

1

Residual tumor (R+)

7 (8%)

b

5 (6%)

  1. One-stage surgery; 30 patients underwent total thyroidectomy without LND, 15 patients receiving central LND, 11 patients receiving central and lateral LND. Two-stage surgery; 2 patients underwent completion thyroidectomy without LND, 29 patients with LND with or without completion thyroidectomy. pNpos (lymph node metastasis diagnosed by histopathology)
  2. pNpos lymph node metastasis diagnosed by histopathology
  3. aRelation to patients who underwent LND
  4. bAll patients with a R + situation underwent LND